Chemoselective Esterification of Phenolic Acids and Alcohols
作者:Giovanni Appendino、Alberto Minassi、Nives Daddario、Federica Bianchi、Gian Cesare Tron
DOI:10.1021/ol0266471
日期:2002.10.1
[formula: see text] The Mitsunobu reaction can distinguish between alcohol and phenol hydroxyls in esterification reactions, providing an expeditious and broadly applicable entry into various phenolics and polyphenolics of biomedical and nutritional relevance.
Evaluation of the Antioxidant Activity of Capsiate Analogues in Polar, Nonpolar, and Micellar Media
作者:Kunduru K. Reddy、Thumu Ravinder、Rachapudi B. N. Prasad、Sanjit Kanjilal
DOI:10.1021/jf104244m
日期:2011.1.26
Synthesis of 10 capsiate analogues was conducted by lipase-mediated (Novozyme 435) esterification of vanillyl alcohol with different fatty acids. The antioxidant activity of the synthesized capsiates was evaluated using three in vitro assays: DPPH radical scavenging assay (polar medium), Rancimat assay (nonpolar medium), and autoxidation of linoleic acid (micellar medium). The objective of this study is to find the influence of structural characteristics of the alkyl chain of capsiate analogues on their antioxidant activity. In these assays, BHT and alpha-tocopherol were used as reference compounds. Both DPPH and Rancimat assays did not show any specific trend of antioxidant activity with the increase in lipophilicity and also with the type of fatty acids grafted to the phenolic moiety. In the Tween 20 micellar system for the inhibition of autoxidation of linoleic acid, vanillyl ester attached to a C18 alkyl chain (vanillyl stearate, oleate and ricinoleate) exhibited maximum inhibition of autoxidation of linoleic acid.
[EN] TERMINALLY UNSATURATED VANILLOIDS AND MEDICINAL APPLICATION THEREOF<br/>[FR] VANILLOÏDES À TERMINAISON INSATURÉE ET LEUR APPLICATION MEDICINALE
申请人:GHISALBERTI CARLO
公开号:WO2008072072A1
公开(公告)日:2008-06-19
[EN] Terminally unsaturated vanilloids for the manufacturing of a medicinal composition to treat capsaicin-responsive conditions. Said vanilloids are devoided of the disadvantage of capsaicin and analogs, namely the discomforting pungency, while retaining several of the their biological and clinically useful properties. [FR] La présente invention concerne des vanilloïdes à terminaison insaturée pour la fabrication d'une composition médicinale pour traiter des conditions réactives à la capsaïcine. Lesdits vanilloïdes sont exempts des effets désagréables de la capsaïcine et analogues, notamment l'âcreté, tout en préservant plusieurs de leurs propriétés biologiques et cliniques bénéfiques.